Related Experiment Videos
Treatment of ventricular tachycardia using an automatic scanning extrastimulus pacemaker
Journal of the American College of Cardiology
|January 1, 1984
Summary
A novel automatic scanning extrastimulus pacemaker successfully treated a patient with drug-resistant ventricular tachycardia. This device effectively terminated all tachycardia episodes without adverse events in a 6-month follow-up.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Recurrent sustained ventricular tachycardia (VT) poses a significant clinical challenge, especially when resistant to conventional and experimental antiarrhythmic drugs.
- Treatment options for refractory VT are limited, necessitating exploration of advanced therapeutic strategies.
Observation:
- A patient with drug-resistant VT underwent implantation of a programmable automatic scanning extrastimulus pacemaker.
- Successful termination of spontaneous and laboratory-induced VT episodes was demonstrated with programmed ventricular extrastimuli prior to device implantation.
Findings:
- The implanted automatic scanning pacemaker successfully terminated all VT episodes over a 6-month period.
- No acceleration of VT rate or induction of ventricular fibrillation was observed during pacemaker interventions.
- The device demonstrated a high efficacy and safety profile in managing refractory VT.
Implications:
- Automatic scanning extrastimulus pacemakers represent a promising therapeutic option for patients with refractory ventricular tachycardia.
- This technology may offer an alternative to more invasive procedures like catheter ablation or ICD implantation in select cases.
- Further research is warranted to evaluate the long-term efficacy and broader applicability of this pacing strategy.